Svanter Bertil Ross

Svanter Bertil Ross's AcademicInfluence.com Rankings

Svanter Bertil Ross

Biology

#8322

World Rank

#11380

Historical Rank

Neuroscience

#1141

World Rank

#1183

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Svanter Bertil Ross Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Svanter Bertil Ross's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)--a useful denervation tool for central and peripheral noradrenaline neurons. (1981) (461)
Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue. (1969) (323)
Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents. (1967) (267)
LONG‐TERM EFFECTS OF N‐2‐CHLOROETHYL‐N‐ETHYL‐2‐BROMOBENZYLAMINE HYDROCHLORIDE ON NORADRENERGIC NEURONES IN THE RAT BRAIN AND HEART (1976) (259)
Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain. (2009) (195)
Inhibition of the neuronal uptake of 5-hydroxytryptamine and noradrenaline in rat brain by (Z)- and (E)-3-(4-Bromophenyl)-N,N-dimethyl-3-(3-pyridyl) allylamines and their secondary analogues (1977) (171)
Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study. (1986) (168)
(Z)-dimethylamino-1-(4-bromophenyl)-1-(3-pyridyl) propene (h 102/09), a new selective inhibitor of the neuronal 5-hydroxytryptamine uptake. (2009) (146)
Selective inhibitors of monoamine oxidase A and B: Biochemical, pharmacological, and clinical properties (1984) (141)
Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT (1990) (140)
The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299. (1997) (127)
Accumulation of tritiated 5-hydroxytryptamine in brain slices. (1967) (124)
Characterization of [3H]Paroxetine Binding in Rat Brain (1988) (122)
On the long‐lasting inhibitory effect of N‐(2‐chloroethyl)‐N‐ethyl‐2‐bromobenzylamine (DSP 4) on the active uptake of noradrenaline (1976) (111)
The pharmacology of zimelidine: A 5‐HT selective reuptake inhibitor (1981) (106)
Increased dopaminergic and 5‐hydroxytryptaminergic activities in male rat brain following long‐term treatment with anabolic androgenic steroids (1999) (105)
Genetic control of plasma dopamine- β -hydroxylase (1973) (100)
Synaptic Concentration of Dopamine in the Mouse Striatum in Relationship to the Kinetic Properties of the Dopamine Receptors and Uptake Mechanism (1991) (98)
Uptake of some tritiated sympathomimetic amines by mouse brain cortex slices in vitro. (2009) (97)
A comparison of the inhibitory activities of iprindole and imipramine on the uptake of 5-hydroxytryptamine and noradrenaline in brain slices. (1971) (96)
The central stimulatory action of inhibitors of the dopamine uptake. (1979) (90)
Inhibitors of neuronal monoamine uptake. 2. Selective inhibition of 5-hydroxytryptamine uptake by alpha-amino acid esters of phenethyl alcohols. (1978) (89)
(S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: a putative 5-HT1A-receptor antagonist. (1990) (88)
Tricyclic antidepressant agents. II. Effect of oral administration on the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices of the midbrain-hypothalamus region of the rat. (2009) (83)
A and B Forms of Monoamine Oxidase Within the Monoaminergic Neurons of the Rat Brain (1986) (82)
Plasma dopamine- -hydroxylase activity in hypertension and various neuropsychiatric disorders. (1972) (81)
Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site. (1986) (76)
Central noradrenaline depletion antagonizes aspects ofd-amphetamine-induced hyperactivity in the rat (2004) (74)
Enzymes related to biogenic amine metabololism and personality charateristics in depressed patients (1980) (74)
LONG‐TERM BIOCHEMICAL AND BEHAVIORAL EFFECTS OF p‐CHLOROAMPHETAMINE IN THE RAT (1978) (73)
A parametric study of the effects of the noradrenaline neurotoxin DSP4 on avoidance acquisition and noradrenaline neurones in the CNS of the rat (1984) (73)
DSP4, a Selective Neurotoxin for the Locus Coeruleus Noradrenergic System. A Review of Its Mode of Action (2014) (70)
Selective effects on NGFI-A, MR, GR and NGFI-B hippocampal mRNA expression after chronic treatment with different subclasses of antidepressants in the rat (2000) (68)
Studies on the absorption, distribution and metabolism of labelled prilocaine and lidocaine in some animal species. (2009) (67)
Evidence for a role of the locus coeruleus noradrenaline system in learning (1980) (67)
Erythrocyte catechol‐O‐methyltransferase activity in a Swedish population (1981) (65)
Inhibition of the uptake of noradrenaline and 5-hydroxytryptamine by chlorphentermine and chlorimipramine. (1972) (61)
BLOCKING ACTION OF SYMPATHOMIMETIC AMINES ON THE UPTAKE OF TRITIATED NORADRENALINE BY MOUSE CEREBRAL CORTEX TISSUES IN VITRO. (2009) (59)
Antagonism of the acute and long-term biochemical effects of 4-chloroamphetamine on the 5-HT neurones in the rat brain by inhibitors of the 5-hydroxytryptamine uptake. (2009) (59)
Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors. (1981) (54)
Low dopamine‐β‐hydroxylase activity in Down's syndrome (1972) (53)
(+)-4-Dimethylamino-2,alpha-dimethylphenethylamine (FLA 336(+)), a selective inhibitor of the A form of monoamine oxidase in the rat brain. (1982) (52)
Efflux of 5-hydroxytryptamine from synaptosomes of rat cerebral cortex. (1977) (45)
On the mode of action of central stimulatory agents. (2009) (43)
Cyclizing compounds. I. Tertiary N-(2-bromobenzyl)-N-haloalkylamines with adrenergic blocking action. (1973) (43)
Behavioral Pharmacology of AR-A000002, a Novel, Selective 5-Hydroxytryptamine1B Antagonist (2003) (42)
Kinetic properties of the accumulation of 3H-raclopride in the mouse brain in vivo (1989) (42)
Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors. (1986) (41)
On the role of the dorsal mesencephalic tegmentum in the control of masculine sexual behavior in the rat: Effects of electrolytic lesions, ibotenic acid and DSP4 (1982) (40)
Selective monoamine oxidase inhibitors. 1. Compounds related to 4-aminophenethylamine. (1978) (39)
Concentration and Uptake of 5-Hydroxytryptamine in Platelets from Cluster Headache and Migraine Patients (1985) (38)
Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in vivo (2004) (36)
T-maze learning, spontaneous activity and food intake recovery following systemic administration of the noradrenaline neurotoxin, DSP4 (1983) (36)
Evidence for involvement of 5-hydroxytryptamine(1B) autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine. (2002) (35)
(R)-(+)-2-[[[3-(Morpholinomethyl)-2H-chromen-8-yl]oxy]methyl] morpholine methanesulfonate: a new selective rat 5-hydroxytryptamine1B receptor antagonist. (1998) (35)
The motor effects of bromocriptine — a review (2004) (35)
A double‐blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression (1982) (34)
Heterogeneous binding of sigma radioligands in the rat brain and liver: possible relationship to subforms of cytochrome P-450. (1991) (34)
[3H] GBR‐12935 Binding to Cytochrome P450 in the Human Brain (1994) (33)
Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets (2005) (33)
CATECHOL-O-METHYL TRANSFERASE INHIBITORS. IN VIVO INHIBITION IN MICE. (2009) (32)
Decreased blood level of 5-dehydroxytryptamine by inhibitors of the membranal 5-hydroxytryptamine uptake. (1976) (32)
Anti-aggressive effect of zimelidine in isolated mice. (2009) (32)
Substituted amphetamine derivatives. II. Behavioural effects in mice related to monoaminergic neurones. (2009) (31)
Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram (2001) (31)
[3H]Desipramine Binding to Rat Brain Tissue: Binding to Both Noradrenaline Uptake Sites and Sites Not Related to Noradrenaline Neurons (1989) (31)
Antagonism by methylphenidate of the stereotyped behaviour produced by (+)‐amphetamine in reserpinized rats (1978) (30)
Changes in extracellular 5-HIAA concentrations as measured by in vivo microdialysis technique in relation to changes in 5-HT release (2004) (30)
Selective inhibition of the a form of monoamine oxidase by 4-dimethylamino-α-methylphenylalkylamine derivatives in the rat (1982) (30)
Synthesis and monoamine oxidase inhibitory activities of alpha-allenic amines in vivo and in vitro. Different activities of two enantiomeric allenes. (1983) (30)
Chronic amitriptyline treatment induces hippocampal NGFI-A, glucocorticoid receptor and mineralocorticoid receptor mRNA expression in rats. (1998) (30)
5-Hydroxytryptamine and avoidance performance in the rat. Antagonism of the acute effect of p-chloroamphetamine by zimelidine, an inhibitor of 5-hydroxytryptamine uptake (1978) (29)
Structural requirements for uptake into serotoninergic neurones. (2009) (29)
Pharmacology of a novel selective 5-hydroxytryptamine1B receptor antagonist, AR-A000002 (2004) (28)
Antagonism of reserpine-induced hypothermia in mice by some beta-adrenoceptor agonists. (2009) (28)
Dopamine-beta-hydroxylase in hypertension. (2009) (28)
Synergism between 5-HT1B/1D and 5-HT1A receptor antagonists on turnover and release of 5-HT in guinea-pig brain in vivo (1999) (27)
Interactions between reserpine and various compounds on the accumulation of [14C] 5-hydroxytryptamine and [3H]noradrenaline in homogenates from rat hypothalamus. (1979) (27)
Inhibition of 3H-dopamine accumulation in reserpinized and normal rat striatum. (2009) (26)
Robalzotan (NAD‐299), a Novel Selective 5‐HT 1A Receptor Antagonist (2006) (26)
Inhibition of the uptake of 3-H-dopamine and 14-C-5-hydroxytryptamine in mouse striatum slices. (2009) (26)
Role of olfactory bulbectomy and DSP4 treatment in avoidance learning in the rat. (1984) (25)
Effects of zimelidine on serotoninergic and noradrenergic neurons after repeated administration in the rat (2004) (25)
Substituted amphetamine derivatives. I. Effect on uptake and release of biogenic monoamines and on monoamine oxidase in the mouse brain. (2009) (25)
Binding of a specific 5-HT uptake inhibitor, [3H]norzimelidine, to rat brain homogenates. (1982) (25)
Enhanced 5-HT metabolism and synthesis rate by the new selective r5-HT1B receptor antagonist, NAS-181 in the rat brain (2000) (25)
On the topology of the norepinephrine transport carrier in rat hypothalamus. The site of action of tricyclic uptake inhibitors. (1978) (25)
DSP4-induced two-way active avoidance impairment in rats: Involvement of central and not peripheral noradrenaline depletion (2004) (25)
Pharmacological and toxicological exploitation of amine transporters (1987) (24)
α1 (but not α2)-Adrenoceptor Agonists in Combination with the Dopamine D2 Agonist Quinpirole Produce Locomotor Stimulation in Dopamine-Depleted Mice (1990) (24)
CATECHOL-OMETHYL TRANSFERASE INHIBITORS. IN VITRO INHIBITION OF THE ENZYME IN MOUSE-BRAIN EXTRACT. (2009) (23)
Is the sigma opiate receptor a proadifen-sensitive subform of cytochrome P-450? (1990) (23)
5-Hydroxytryptamine depletion and avoidance acquisition in the rat. Antagonism of the long-term effects of p-chloroamphetamine with a selective inhibitor of 5-hydroxytryptamine uptake (1976) (23)
Dopamine‐mediated behaviours produced in naive mice by bromocriptine plus SKF 38393 (1988) (23)
Serotonin involvement in aversive conditioning: Reversal of the fear retention deficit by long-term p-chloroamphetamine but not p-chlorophenylalanine (1982) (23)
Neuronal transport of 5-hydroxytryptamine. (1980) (22)
Role of descending monoaminergic neurons in the control o sexual behavior: Effects of intrathecal infusions of 6-hydroxydopamine and 5,7-dihydroxytryptamine (1983) (22)
IN VIVO INACTIVATION OF CATECHOLAMINES IN MICE. (2009) (22)
Stereospecificity of the enzymatic biotransformation of the enantiomers of prilocaine (Citanest). (2009) (21)
Active and passive avoidance following the administration of systemic DSP4, xylamine, or p-chloroamphetamine. (1985) (21)
Electrophoretic properties of dopamine -hydroxylase in several tissues from three species. (1972) (21)
INHIBITORS OF THE ENZYMATIC HYDROXYLATION OF PHENYLALANINE AND TRYPTOPHAN BY RAT LIVER EXTRACT IN VITRO. (1964) (21)
In vitro characterization of AR-A000002, a novel 5-hydroxytryptamine(1B) autoreceptor antagonist. (2004) (21)
Anti‐aggressive action of dopamine‐β‐hydroxylase inhibitors in mice (1976) (21)
Distribution of the Two Forms of Monoamine Oxidase Within Monoaminergic Neurons of the Guinea Pig Brain (1987) (21)
Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression (2004) (20)
Forebrain projections of the ventral tegmentum as studied by axonal transport of [3H]dopamine in the rat (1979) (20)
Selective monoamine oxidase inhibitors. 4. 4-Aminophenethylamine derivatives with neuron-selective action. (1986) (20)
Evidence for involvement of protein kinases in the regulation of serotonin synthesis and turnover in the mouse brain in vivo (2002) (19)
Kinetics and Thermolability of Platelet Monoamine Oxidase in Cluster Headache and Migraine (1984) (19)
Monoamine oxidase in human platelets. Kinetics and methodological aspects. (1981) (19)
N-2-chloroethyl-N-ethyl-2-bromobenzylamine hydrochloride (DSP4), a new selective noradrenaline neurotoxin, and taste neophobia in the rat (1981) (19)
Synthesis of pyridylallylamines related to zimelidine and their inhibition of neuronal monoamine uptake. (1981) (18)
Acute effects of zimelidine and alaproclate, two inhibitors of serotonin uptake, on neuroendocrine function (1979) (18)
Release of 3H-noradrenaline from the rat vas deferens under various in vitro conditions. (1979) (18)
Dopamine-β-hydroxylase in human lymph (1974) (18)
The involvement of dopamine D1 and D2 receptors in the locomotor stimulation produced by (+)-amphetamine in naive and dopamine-depleted mice. (1989) (18)
Inhibition of [3H]paroxetine binding by various serotonin uptake inhibitors: structure-activity relationships. (1992) (17)
Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain (1983) (17)
Long-term effects of N-2-chlorethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurones in the rat brain and heart. (1976) (17)
Selective inhibition of monoamine oxidase by p-aminosubstituted phenylalkylamines in catecholaminergic neurones (1986) (17)
Differential regional antagonism of 8-OH-DPAT-induced decrease in serotonin synthesis by two 5-HT1A receptor antagonists. (1998) (16)
Platelet monoamine oxidase in a pedigree with schizophrenia: an interlaboratory project (1979) (16)
Unaltered [3H]GBR-12935 binding after chronic treatment with dopamine active drugs (2005) (16)
Homoallylic amines related to zimeldine. A comparative study on neuronal serotonin and norepinephrine reuptake based on conformational analysis. (1988) (16)
Time course of bromocriptine induced excitation in the rat: behavioural and biochemical studies (1995) (16)
Evidence for a selective inhibition by FLA 336(+) of the monoamine oxidase in serotonergic neurones in the rat brain. (2009) (15)
Antidepressant agents. 1. Chemistry and pharmacology of amino-substituted spiro(5H-dibenzo(a,d)cycloheptene-5,1'-cycloalkanes). (1974) (15)
Serum dopamine-beta-hydroxylase in affective disorders. (1978) (15)
On the fate of dopamine-beta-hydroxylase after release from the pheripheral sympathetic nerves in the cat. (1974) (15)
In vivo labelling of the mouse brain 5-hydroxytryptamine1A receptor with the novel selective antagonist 3H-NAD-299 (1998) (15)
Potentiation by reserpine of the inhibition by amphetamine of [3H]dopamine accumulation in the rat striatum (1977) (15)
Development of tolerance to 8-OH-DPAT induced blockade of acquisition of a passive avoidance response (1994) (15)
Effect of destruction of central noradrenergic and serotonergic nerve terminals by systemic neurotoxins on the long-term effects of antidepressants onβ-adrenoceptors and 5-HT2 binding sites in the rat cerebral cortex (2005) (15)
On the mechanism of the acute decrease of rat brain tryptophan hydroxylase activity by 4-chloroamphetamine (1977) (13)
Active transport of 3H-bretylium in the rat vas deferens in vitro. (1976) (13)
Effect of (+)-amphetamine on the retention of 3H-catecholamines in slices of normal and reserpinized rat brain and heart. (2009) (13)
The effect of acute zimeldine and alaproclate administration on the acquisition of two-way active avoidance: Comparison with other antidepressant agents, test of selectivity and sub-chronic studies (2004) (13)
Effects of acute and repeated administration of amiflamine on monoamine oxidase inhibition in the rat. (1984) (13)
2810 – A NEW NEUROTOXIC COMPOUND AS DENERVATION TOOL FOR NORADRENALINE NEURONS (1978) (13)
Stereoselective high-affinity binding of 3H-alaproclate to membranes from rat cerebral cortex. (1987) (12)
A PLS quantitative structure-activity relationship study of some monoamine oxidase inhibitors of the phenyl alkylamine type (1994) (12)
On the mechanism of the accumulation of 3H-bretylium in peripheral sympathetic nerves (2004) (12)
Genetic studies of CSF monoamine metabolites. (1984) (12)
Effects of amiflamine and related compounds on the accumulation of biogenic monoamines in rat brain slices in vitro and ex vivo in relation to their behavioural effects. (2009) (12)
Genetic control of plasma dopamine-beta-hydroxylase. (1973) (12)
Further studies on the interaction between bromocriptine and SKF38393 in reserpine and alpha methyl-para-tyrosine-treated mice (2004) (12)
Effect of veratridine on the fluxes of 3H-noradrenaline and 3H-bretylium in the rat vas deferens in vitro (1976) (12)
Alpha 1 (but not alpha 2)-adrenoceptor agonists in combination with the dopamine D2 agonist quinpirole produce locomotor stimulation in dopamine-depleted mice. (1990) (12)
Selective monoamine oxidase inhibitors. 3. Cyclic compounds related to 4-aminophenethylamine. Preparation and neuron-selective action of some 5-(2-aminoethyl)-2,3-dihydroindoles. (1986) (12)
Effects of zimelidine on various transmitter systems in the brain. (1982) (11)
Intra- and extraneuronal monoamine oxidase. (1984) (11)
Rapid and long-lasting tolerance to clomethiazole-induced hypothermia in the rat. (2005) (11)
GENETICS AND BIOCHEMISTRY OF SCHIZOPHRENIA IN A DEFINED POPULATION (1979) (11)
The pharmacological profile of (R)-3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a selective 5-hydroxytryptamine(1A) receptor agonist. (2001) (11)
Inhibition of choline acetyltransferase by 2-dimethylaminoethyl chloroacetate and related compounds. (2009) (11)
Catechol-O-methyltransferase activity in human erythrocytes: methodological aspects. (1981) (11)
INHIBITORS OF NEURONAL MONOAMINE UPTAKE. III. SYNTHESIS AND PHARMACOLOGIC SCREENING OF ALAPROCLATE ANALOGS (1982) (10)
The Forgotten 5‐Hydroxyindoleacetic Acid (1997) (10)
C8-substituted derivatives of 2-(dipropylamino)tetralin: Palladium-catalyzed synthesis and interactions with 5-HT1A-receptors (1991) (10)
[3H]GBR-12935 binding to dopamine uptake sites in rat striatum. (1990) (9)
α1‐Adrenoceptor function in the rat hippocampus as assessed by noradrenaline‐stimulated inositol phospholipid breakdown after destruction of noradrenergic neurons by neonatal 6‐hydroxydopamine treatment (1986) (9)
N-Methyl-D-aspartate receptor antagonists counteract the long lasting 5-HT1A receptor-induced attenuation of postsynaptic responses in the rat in vivo (1992) (9)
Dopamine D-2 receptor agonist-induced behavioural depression: critical dependence upon postsynaptic dopamine D-1 function (1989) (9)
Long lasting attenuation of 8-OH-DPAT induced corticosterone secretion after a single injection of a 5-HT1A receptor agonist (1992) (9)
D1 and D2 dopamine agonist synergism and the nucleus accumbens (1987) (9)
Inhibition of liver phenylalanine and tryptophan hydroxylating enzyme systems in vitro and in vivo. (2009) (9)
Dopamine D2 agonist-induced behavioural depression is reversed by dopamine D1 agonists (2005) (9)
In vitro inhibition of noradrenaline-3H uptake by reserpine and tetrabenazine in mouse cerebral cortex tissues. (2009) (9)
Differential sensitivity to 8-hydroxy-2-(di-n-propylamino)tetralin-induced corticosterone secretion and hypothermia between Sprague-Dawley rats from different breeding colonies. (2001) (9)
Attenuation of the post-decapitation convulsions after repeated treatment of rats with desipramine, imipramine and maprotiline. (2009) (9)
DSP4 and behavioural experiments (1985) (8)
Psychoses in twins A 10 year clinical and biochemical follow-up study (1989) (8)
Antagonism of 5‐methoxy‐N,N‐dimethyltryptamine‐induced changes in postdecapitation convulsions in rats by repeated treatment with drugs enhancing 5‐hydroxytryptamine neurotransmission (1985) (8)
Catecholaminergic activity in idiopathic torsion dystonia (1987) (8)
Kinetic aspects of monoamine oxidase activity in twins with psychoses (1981) (8)
EFFECTS OF VARIOUS COMPOUNDS ON ADRENERGIC MECHANISMS RECORDED BY CHANGES IN HEART RATES OF ANESTHETISED MICE. (2009) (8)
Proadifen-sensitive high affinity binding of 3H-alaproclate to liver membranes. (1987) (8)
Cyclization of three N- -haloalkyl-N-methylaminoaceto-2,6-xylidide derivatives in relation to their local anesthetic effect in vitro and in vivo. (1972) (8)
Activation of monoamine oxidase by high molecular weight fractions of human plasma. (1984) (8)
Active uptake of tritiated metaraminol by mouse brain slices in vitro. (1966) (8)
Biochemical and behavioural effects of isamoltane, a β-adrenoceptor antagonist with affinity for the 5-HT1B receptor of rat brain (2004) (7)
5-Hydroxytryptamine and learning: long-term effects of P-chloroamphetamine on acquisition. (1975) (7)
Stereoselective effects of the potentially neuroleptic rigid spiro amines (1976) (7)
Inhibitors of serotonin and noradrenaline uptake in human plasma after withdrawal of zimelidine and clomipramine treatment (2004) (7)
Cyclizing compounds. 3. Local anesthetic action of N-(omega-haloalkyl)-N-methylaminoaceto-2,6-xylidides. (1973) (7)
The enzymatic hydrolysis of a series of aminoacylanilides in relation to their nerve blocking effect and toxicity. (2009) (7)
Enhancement by a single dose of reserpine (plus alpha methyl-p-tyrosine) of the central stimulatory effects evoked by dopamine D-1 and D-2 agonists in the mouse (1988) (7)
Serum dopamine-beta-hydroxylase and the augmenting-reducing response. (1980) (7)
Cortical beta- and alpha 2- adrenoceptor binding, hypothalamic noradrenaline and pineal melatonin concentrations measured at different times of the day after repeated treatment of rats with imipramine, zimeldine, alaproclate and amiflamine. (2009) (7)
Serum dopamine-beta-hydroxylase in diagnostic subgroups of depressed patients and in relation to their personality characteristics. (1983) (7)
Effects of long-term administration of the 5-hydroxytryptamine1B receptor antagonist AR-A000002 to guinea pigs (2004) (7)
A conformational study of R-alaproclate, a new selecetive inhibitor of neuronal 5-hydroxytryptamine uptake (1978) (6)
Catechol‐O‐methyltransferase activity in erythrocytes in Down's syndrome: family studies (1982) (6)
Low dopamine-beta-hydroxylase activity in Down's syndrome. (1972) (6)
Maximal turnover number of the membranal serotonin carrier in rat brain synaptosomes in vitro. (1983) (6)
Troxonium-like inhibitors of the high affinity uptake of choline in mouse brain synaptosomes in vitro. (1984) (6)
Inhibition of Monoamine Oxidase Within Monoaminergic Neurons in the Rat Brain by (E)‐β‐Fluoromethylene‐m‐Tyrosine (MDL 72394) (1989) (6)
[3H]WIN 35,428 binding in the human brain (1996) (6)
Behavioural, biochemical and electrophysiological studies on the motor depressant and stimulant effects of bromocriptine (1990) (6)
Inhibitors of neuronal monoamine uptake. I. Selective inhibition of 5-hydroxytryptamine uptake by alpha-aminoacid amides of phenethylamines. (1978) (6)
Failure to detect in vivo inverse agonism of the 5-HT1B receptor antagonist SB-224289 in 5-HT-depleted guinea-pigs (2002) (6)
Antidepressant agents. 9. 3,3-Diphenylcyclobutylamines, a new class of central stimulants. (1978) (6)
The inhibition of the cage-leaving response—A model for studies of the serotonergic neurotransmission in the rat (2005) (6)
Modulation of neuronal glutamate transporter rEAAC1 mRNA expression in rat brain by amitriptyline. (2004) (6)
Pharmacological Manipulation of Biochemically Measured Rhythms in the Mammalian Central Nervous System (1985) (6)
Measurement of intraneuronal monoamine oxidase in the brain (1986) (5)
Long-term effects of N-hydroxy-4-chloroamphetamine on the level and accumulation of 5-hydroxytryptamine in the rat brain. (1974) (5)
Further studies on the high-affinity binding of 3H-alaproclate to membranes from rat liver and some other tissues. (1990) (5)
Formation of a quaternary derivative in mouse brain after administration of N-(5'-chloropentyl)-N-methylaminoaceto-2,6-xylidide. (1970) (5)
Subchronic treatment of rats with remoxipride fails to modify σ binding sites in the brain (1992) (5)
Dopamine-beta-hydroxylase after treatment with beta-blockers in hypertension. (1975) (4)
AR-A000002, a high affinity 5-HT1B receptor antagonist: Pharmacological characterisation (2001) (4)
Synthesis of [3H]proadifen for studying binding to liver membranes (1993) (4)
Clenbuterol, a central beta-adrenoceptor agonist. (1980) (4)
Heterogenous binding of 3H-remoxipride to membranes of rat liver and brain. (1995) (4)
A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a norepinephrine uptake inhibitor, in endogenous depression: clinical and biochemical findings. (1984) (4)
Prodrugs of neuron-selective monoamine oxidase inhibitors: amino acid derivatives of 1-(4-aminophenyl)-2-aminopropanes (1999) (4)
Release of 3H-5-hydroxytryptamine by amiflamine and related phenylalkylamines from rat occipital cortex slices (1989) (4)
Kinetic aspects of human platelet monoamine oxidase thermolability. (1984) (4)
Pharmacokinetics of haloalkylamines: cyclization and distribution in blood in vitro and in vivo (1975) (4)
Formation of a piperidinium derivative from N-(5'-chloropentyl)-N-methylaminoaceto-2,6-xylidide in relation to the sustained local anaesthetic action on the sciatic nerve of the guinea-pig in vivo. (1971) (4)
Plasma dopamine β‐hydroxylase activity in a North Swedish isolate with a high frequency of schizophrenia (1981) (4)
Inhibition of 5-hydroxytryptamine accumulation and deamination by substituted phenylalkylamines in hypothalamic synaptosomes from normal and reserpine-pretreated rats (1987) (3)
SYNTHESIS OF PYRIDYLALLYLAMINES RELATED TO ZIMELIDINE AND THEIR INHIBITION OF NEURONAL MONOAMINE UPTAKE (1982) (3)
Selective monoamine oxidase inhibitors. II. 4-aminophenylalkylamine derivatives. (1983) (3)
Counteraction of the rapid tolerance to 8-hydroxy-2-(di-n-propylamino)tetralin-induced hypothermia in rats by activation of the GABAA receptor-chloride channel complex. (2002) (3)
Counteraction of the rapid tolerance to 8‐OH‐DPAT‐induced corticosterone secretion in rats by activation of the GABAA receptor‐chloride channel complex (1993) (3)
Hypothermia reduces the rate of dissociation of specific ligands from dopamine-D2 and 5-hydroxytryptamine1A receptors in the mouse brain in vivo (2001) (3)
Localization and Inhibition of Monoamine Oxidase (1988) (3)
Evoked efflux of 3H-bretylium by sympathomimetic amines from the rat vas deferens in vitro. (2009) (3)
Kinetics of 5-Hydroxytryptamine Uptake into Platelets and 5-Hydroxytryptamine Concentration in Whole Blood in Migraine and Cluster Headache Patients (1985) (3)
Ionic influence on human erythrocyte catechol-O-methyltransferase activity. (1981) (3)
Anti-aggressive action of dopamine-beta-hydroxylase inhibitors in mice. (1976) (3)
Effects of reduced cerebral serotonin on learning (1977) (3)
The preparation and pharmacological properties of 3-acetyltyrosine and 3-acetyltyramine. (1978) (3)
Active and passive avoidance performances following bilateral olfactory bulbectomy. (1984) (2)
Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid of chronic therapy-resistant schizophrenics before and after hemodialysis therapy. (1983) (2)
Unaltered 5-HT- and desipramine-sensitive [3H]imipramine binding and [3H]5-HT uptake in rat brain after chronic imipramine and norzimeldine treatment (2004) (2)
Antidepressant agents. II. Thiophene analogues of amitriptyline and nortriptyline. (1974) (2)
Subject Index Vol 23, 1991 (1990) (2)
Chemistry and CNS-effects of 2-aminomethyl-2'--hydroxybiphenyls and 2-aminomethyl-2' 3'-dihydroxybiphenyls. (1977) (2)
The new (R) -5-carbamoyl-8-fluoro-3-N, N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans (1994) (2)
Failure to detect any transport of the irreversible monoamine oxidase inhibitor n-cyclopropyl-4-chloroamphetamine by the carrier of 5-hydroxytryptamine in the brain of the rat in vivo (1986) (2)
Selective monoamine oxidase inhibitors. Compounds derived from phenethylamine and 1-phenoxy-2-aminopropane. (1983) (2)
A CONFORMATIONAL STUDY OF R-ALAPROCLATE, A NEW SELECTIVE INHIBITOR OF NEURONAL 5-HYDROXYTRYPTAMINE UPTAKE (1978) (2)
NMDA receptor-mediated increase in cyclic GMP in the rat cerebellum in vivo is blocked by alaproclate and GEA-857. (1997) (2)
Antidepressant agents. V. 1,1-Dimethyl-omega,omega-diphenylalkylamines. (1975) (2)
Retention deficits induced by acute p-chloroamphetamine following fear conditioning in the rat (1983) (2)
Serotonin selective reuptake inhibitors — relationship between chemical structure and pharmacological effects (1983) (2)
Subchronic treatment of rats with remoxipride fails to modify sigma binding sites in the brain. (1992) (2)
Comparison of high affinity binding of 3H-proadifen and 3H-(-)-cocaine to rat liver membranes. (1995) (2)
C8-Substituted Derivatives of 2-(Dipropylamino)tetralin: Palladium- Catalyzed Synthesis and Interactions with 5-HT1A-Receptors. (1993) (2)
Dopamine-beta-hydroxylase and plasma renin activity in twenty hypertensive subjects. (1975) (2)
Selective inhibition by 4,alpha-dimethyl-m-tyramine (H77/77) and 4-methyl-alpha-ethyl-m-tyramine (H75/12) of the monoamine oxidase within serotonergic and noradrenergic neurons in the rat brain. (1988) (1)
No change in responsiveness of 5-HT1A receptors after long-term treatment with the novel 5-HT1A receptor antagonist robalzotan (NAD-299) in rats (1998) (1)
THE MODE OF ACTION OF CENTRAL STIMULATORY AGENTS (1979) (1)
Selective Monoamine Oxidase Inhibitors. Part 3. Cyclic Compounds Related to 4-Aminophenethylamine. Preparation and Neuron-Selective Action of Some 5-(2-Aminoethyl)-2,3-dihydroindoles. (1987) (1)
Selective inhibition by 4,α-dimethyl-m-tyramine (H77/77) and 4-methyl-α-ethyl-m-tyramine (H75/12) of the monoamine oxidase within serotonergic and noradrenergic neurons in the rat brain (1988) (1)
Antidepressant agents. 3. Aza-analogues of etryptamine. (1974) (1)
SELECTIVE MONOAMINE OXIDASE INHIBITORS. PART 1. COMPOUNDS RELATED TO 4-AMINOPHENETHYLAMINE (1978) (1)
Cyclizing compounds. II. Tertiary N-(2-(2,6-dimethylphenoxy)ethyl)-N-haloalkylamines with local anaesthetic action. (1973) (1)
Compounds interfering with the metabolism, uptake and storage of catecholamines and 5-hydroxytryptamine (1967) (1)
Antidepressant agents. VII. Enantiomers of 3,3-diphenylcyclopentylamine and 4,4-diphenylcyclohex-2-enylamine. Selective inhibition of amine uptake. (1976) (1)
AR-A000002, a high affinity 5-HT1B receptor antagonist: Effects of subchronic treatment of guinea pigs (2001) (1)
α1-adrenoceptor agonists behave like depsiniine D agonists in reinstating quinpirole-induced Eocomotor stimulation blocked by dopamine depletion in mice (1990) (1)
INHIBITORS OF NEURONAL MONOAMINE UPTAKE. PART 2. SELECTIVE INHIBITION OF 5-HYDROXYTRYPTAMINE UPTAKE BY α-AMINO ACID ESTERS OF PHENETHYL ALCOHOLS (1978) (1)
Low serum dopamine-beta-hydroxylase activity in the dysequilibrium syndrome. (1977) (1)
Clenbuterol, a Central β‐Adrenoceptor Agonist (2009) (1)
Dopamine-beta-hydroxylase in human lymph. (1974) (0)
ANTIDEPRESSANT AGENTS. PART 9. 3,3-DIPHENYLCYCLOBUTYLAMINES, A NEW CLASS OF CENTRAL STIMULANTS (1978) (0)
ANTIDEPRESSANT AGENTS PART 1, CHEMISTRY AND PHARMACOLOGY OF AMINO-SUBSTITUTED SPIRO(5H-DIBENZO(A,D)CYCLOHEPTENE-5,1′-CYCLOALKANES) (1974) (0)
AR-A000002, a high affinity 5-HT1B receptor antagonist: Evaluation of its anxiolytic potential (2001) (0)
Sedative 1,2,3-thiadiazoles. (1973) (0)
Compounds related to clomethiazole. 3. 4,5-dialkyl-substituted thiazoles, oxazoles and imidazoles. (1970) (0)
SELECTIVE INHIBITION OF MONOAMINE OXIDASE TYPE A BY SOME 4-AMINOPHENYLISOPROPYLAMINE COMPOUNDS (1980) (0)
Aminosaeureester, methods for their manufacture and to compositions comprising drug (1976) (0)
49-5 Chronic administration of antidepressants induce GR and NGFI-A gene expression (1997) (0)
DSP4, a Selective Neurotoxin for the Locus Coeruleus Noradrenergic System. A Review of Its Mode of Action (2014) (0)
Derives de 1,2,3,4-tetrahydronaphthalene substitues (1997) (0)
Abstracts from the 5th Meeting on Adrenergic Mechanisms (1984) (0)
A combination of a 5-HT1A antagonist and selective antagonist or partial agonist selective h5-HT1B. (1998) (0)
Antidepressant agents. X. Diphenyl-substituted cycloheptyl- and bicycloheptylamines. (1978) (0)
Analogifremgangsmaade for the preparation of 3- (4-bromfenyl) -N-methyl-3- (3-pyridyl) -allylamin in the Z-form or E-form, or a pharmaceutically acceptable salt thereof (1975) (0)
Antidepressant agents. VI. 4,4-Diphenyl-1-methylcyclohexylamines. (1975) (0)
Serum dopamine-beta-hydroxylase activity in patients with major depressive disorders. (1986) (0)
10-Aminoacylphenothiazines. IV. Derivatives of sterically hindered amines. (1968) (0)
Indane substituted derivatives. (1998) (0)
Bromocriptine — further behavioural and biochemical studies (1994) (0)
Contents, Vol. 23, 1990-1991 (1990) (0)
1,2,3,4-tetrahydronaphthalene derivatives substituted. (1998) (0)
Selective Monoamine Oxidase Inhibitors. Part 4. 4-Aminophenethylamine Derivatives with Neuron-Selective Action. (1987) (0)
A combination of a monoamine oxidase and an antagonist or partial agonist h5-HT1 beta. (1998) (0)
CYCLIZING COMPOUNDS PART 3, LOCAL ANESTHETIC ACTION OF N-(OMEGA-HALOALKYL)-N-METHYL-AMINOACETO-2,6-XYLIDIDES (1973) (0)
Analogifremgangsmaade for preparing trifluormetylsubstituerede aralkyl esters of alanine or pharmaceutically acceptable acid addition salts thereof (1976) (0)
Cyclizing compounds. V. Tertiary haloalkylamine derivatives related to the tricyclic psychopharmacological agents promazine, imipramine and amitriptyline. (1984) (0)
A process for the synthesis of 2'-0-substituted pyrimidines and oligomers thereof (1996) (0)
Derivatives of phenyl-pyrioylamine (1975) (0)
Monoamine oxidase inhibitor and h5-HT 1 beta antagonist or partiellagonist mixture containing (1998) (0)
A process for preparing cykloalkylaminer (1978) (0)
Analogifoerfarande Foer framstaellning of nya aralkylestrar of amino acids with antidepressiv Effect (1975) (0)
The use of DSP4 as a noradrenaline neurotoxin requires the recovery of the animals from the acute effects of the drug (1985) (0)
On thiophene analogues of metaqualone-like compounds. (1968) (0)
Process for novel therapeutically active chroman and the preparation of intermediates and tiokromaanijohdannaisten (1991) (0)
SYNTHESIS AND MONOAMINE OXIDASE INHIBITORY ACTIVITIES OF α-ALLENIC AMINES IN VIVO AND IN VITRO. DIFFERENT ACTIVITIES OF TWO ENANTIOMERIC ALLENES (1983) (0)
Amphetamine derivatives, processes for their preparation and to compositions comprising drug (1974) (0)
Prodrugs of Neuron‐Selective Monoamine Oxidase Inhibitors: Amino Acid Derivatives of 1‐(4‐Aminophenyl)‐2‐aminopropanes. (1999) (0)
Labelled compounds of potential biological interest. IV. Tritium labelling of some cyclzing compounds (1977) (0)
antagonist combination of 5-HT reuptake inhibitors and h5-HT 1B or partial agonist (1998) (0)
substituted indane derivatives (1998) (0)
Substituted 1,2,3,4-tetrahydronaphthalene (1997) (0)

This paper list is powered by the following services:

Svanter Bertil Ross's Academic­Influence.com Rankings

Why Is Svanter Bertil Ross Influential?

Svanter Bertil Ross's Published Works

Published Works

Svanter Bertil Ross's AcademicInfluence.com Rankings